Seres Therapeutics, Inc. (MCRB) Operating margin 2016–2025
Seres Therapeutics, Inc. (MCRB) operating margin by fiscal year — reported operating income divided by reported revenue.
-11910.1%FY2025 · since FY2016: -426.5% → -11910.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11910.1% | — |
| FY2022 | -2524.0% | -2479.2 pp |
| FY2021 | -44.8% | +695.9 pp |
| FY2020 | -740.8% | -476.4 pp |
| FY2019 | -264.4% | +108.2 pp |
| FY2018 | -372.6% | -87.8 pp |
| FY2017 | -284.7% | +141.8 pp |
| FY2016 | -426.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice